En savoir plus
Informationen zum Autor Angela L. Myers, MD, MPH, FAAP, is a board-certified pediatric infectious diseases physician and is currently an Assistant Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine. She is the pediatric infectious diseases fellowship director at Children's Mercy Hospital & Clinics. Dr. Myers received her undergraduate and medical degree from the University of Missouri-Kansas City School of Medicine in the combined 6-year program, and completed her pediatrics residency and pediatric infectious diseases fellowship at Children's Mercy Hospitals & Clinics. Active in research, her main interests revolve around childhood and adult vaccine knowledge, attitudes, and beliefs, as well as using novel health information technologies to improve vaccination rates for influenza. She currently oversees several funded studies evaluating vaccine beliefs as well as implementation of various strategies to increase immunization rates of both children and adults. She is the author of 2 book questions and more than 15 publications in pediatric journals and is also actively involved in committee work for the Pediatric Infectious Diseases Society program training committee and the graduate medical education council at her affiliated medical school. Klappentext Curbside Consultation in Pediatric Infectious Disease: 49 Clinical Questions provides quick answers to the tricky questions most commonly posed during a "curbside consultation" between pediatricians. Zusammenfassung Curbside Consultation in Pediatric Infectious Disease: 49 Clinical Questions provides quick answers to the tricky questions most commonly posed during a "curbside consultation" between pediatricians. Inhaltsverzeichnis Dedication Acknowledgments About the Editor Contributing Authors Preface Foreword by Janet R. Gilsdorf, MD Introduction Section I?Urinary Tract Infection Question 1 Is It Appropriate to Treat a Suspected Urinary Tract Infection Based on an In Office Urine Dipstick Result, or Should the Specimen Be Sent for Culture? Does the Age of the Patient Have Anything to Do With the Decision? Rene Vandevoorde, MD Question 2 When Should You Attempt to Obtain a Catheter Specimen Versus a Clean Catch Specimen in the Setting of a Suspected Urinary Tract Infection? Rene Vandevoorde, MD Question 3 When Is Imaging, Such As voiding cystourethrogram (VCUG) and Renal Ultrasound, Necessary for Children With a First Urinary Tract Infection? Rene Vandevoorde, MD Question 4 Is Prophylaxis Recommended for All Patients With Vesicoureteral Reflux? Rene Vandevoorde, MD Section II?Methicillin-Resistant Staphylococcus Aureus Question 5 When Is Oral Antibiotic Therapy Necessary in the Setting of Recurrent Methicillin-resistant Staphylococcus Aureus (MRSA) Skin Infection/Boils? Emily A. Thorell, MD Question 6 Are Bleach Baths or Chlorhexidine Plus Mupirocin Ointment Useful to Decolonize Patients With Recurrent Methicillin-resistant Staphylococcus Aureus (MRSA) Infections? What Topical Recommendations Are Useful for Patients With Recurrent MRSA Infections? Emily A. Thorell, MD Question 7 In What Settings Is Methicillin-resistant Staphylococcus Aureus (MRSA) Spread? Emily A. Thorell, MD Question 8 Are There Environmental Cleaning or Personal Hygiene Interventions That Can Be Used To Reduce Recurrences of Methicillin-resistant Staphylococcus Aureus (MRSA) Infections? Emily A. Thorell, MD Section III?Tinea Capitis Question 9 How Long Does Tinea Capitis Need To Be Treated in Order to Be Sure the Infection Has Cleared? Jennifer Goldman, MD and Susan Abdel-Rahman, PharmD Question 10 What Are the Methods by Which Tinea Capitis Can Be Spread From Person To Person? Jennifer Goldman, MD and Susan Abdel-Rahman, PharmD Question 11 Do There Need to Be Visible Lesions to Diagnose Tinea Capitis? Jennifer Goldman, MD and Susan Abdel-Rahman, PharmD Question 12 What Organisms Are Responsible for Causing Tinea Capitis? Je...
